女歌星
发表于 2025-3-27 00:23:56
http://reply.papertrans.cn/83/8285/828471/828471_31.png
休闲
发表于 2025-3-27 03:39:27
Definitions of Resistant Hypertension and Epidemiology of Resistant Hypertension,th estimates ranging from 3% to 34%. A significant proportion of this variability reflects the different measures taken to exclude patients with pseudo-resistant hypertension (e.g., white coat syndrome) and inconsistent interpretations of the definition. The adverse impact of resistant hypertension
洞察力
发表于 2025-3-27 06:31:02
Resistant Hypertension and Outcomes in Patients with and Without Chronic Kidney Disease, aTRH are known to have a greater burden of cardiovascular risk factors and target organ damage with a 50% greater chance of experiencing an adverse cardiovascular event over a median follow-up of 4 years compared to patients with nonresistant hypertension. The prevalence of aTRH in CKD incrementall
CLASP
发表于 2025-3-27 12:36:13
Risk Stratification of Resistant Hypertension in Chronic Kidney Disease,he management of RHTN, first of all, the differential diagnosis should be made in between the TR and pseudoresistance. Ambulatory blood pressure monitoring is very important in this context. Comorbid conditions such as diabetes mellitus, smoking, obesity, obstructive sleep apnea, and renal artery st
Bureaucracy
发表于 2025-3-27 16:49:12
Pathophysiological Insights in Resistant Hypertension,haracterize the distinct entity called refractory hypertension. More than the description of mechanisms involved in RH, our aim is to shed light on the authenticity of this disease, as well as on the features which distinguish it from other forms of hypertension.
BRAVE
发表于 2025-3-27 18:07:35
http://reply.papertrans.cn/83/8285/828471/828471_36.png
声音刺耳
发表于 2025-3-27 22:13:31
Secondary Causes: Work-Up and Its Specificities in CKD: Influence of Arterial Stiffening,atory blood pressure monitoring, etc.) with information derived from arterial stiffness assessment may represent an accurate and cost-effective approach for individualizing CKD and HTN patients’ care and treatment.
哑巴
发表于 2025-3-28 04:57:40
Secondary Causes: Work-Up and Its Specificities in CKD: Influence of Autonomic Dysfunction,hypertension and the mechanisms responsible for this autonomic dysfunction. The use of novel non-pharmacological approaches for sympathoinhibition in resistant hypertension is discussed in light of the recent clinical trials. Finally, particular aspects regarding the mechanistic role of sympathetic
Assault
发表于 2025-3-28 07:51:46
http://reply.papertrans.cn/83/8285/828471/828471_39.png
大约冬季
发表于 2025-3-28 13:00:33
Public Health Efforts for Earlier Resistant Hypertension Diagnosis, Reduction of Salt Content in Fobe effective in diminishing BP in RHT patients. Reducing dosage demands is defined as the most effective single approach to improve adherence. Reducing dosing can be provided by the use of a fixed-dose combination (FDC) polypill consisting of the recommended treatments in a single daily capsule. Thi